January 30, 2019
MORE – Monitoring Revlimid – Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry
Read More
December 10, 2018
Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV)
Read More
December 10, 2018
Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia
Read More
December 10, 2018
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Read More
December 10, 2018
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
Read More
December 10, 2018
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
Read More
December 10, 2018
A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
Read More
December 10, 2018
Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia
Read More
December 10, 2018
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission
Read More
December 10, 2018
A Safety and Efficacy Study of Oral AG-120 Plus Subcutaneous Azacitidine and Oral AG-221 Plus Subcutaneous Azacitidine in Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML)
Read More
December 10, 2018
Italian Network MDS Registry
Read More
December 10, 2018
Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Read More
Load More
X